Literature DB >> 27002606

Effect of IFN-γ, IL-12 and IL-10 cytokine production and mRNA expression in tuberculosis patients with diabetes mellitus and their household contacts.

Ponnana Meenakshi1, Sivangala Ramya1, Joshi Lavanya1, Valluri Vijayalakshmi2, Gaddam Sumanlatha3.   

Abstract

OBJECTIVE: The study was carried out to understand the influence of IFN-γ, IL-12 and IL-10 cytokine production and expression in tuberculosis patients with diabetes mellitus (TBDM) and their household contacts (HHC).
METHODOLOGY: The study involved a total of 300 subjects, 50 in each category of TBDM, TBDM HHC, pulmonary tuberculosis patients (PTB), PTB HHC, DM and healthy controls (HC). TBDM, PTB and their HHC, 25 each were followed at different intervals to determine their immune responses in Ag85A stimulated culture supernatants by Enzyme Linked Immunosorbent Assay (ELISA). mRNA expression by TRIZOL method in 5 cases of each category and follow-up studies were performed.
RESULTS: IFN-γ and IL-12 cytokine production markedly decreased and that of IL-10 increased after Ag85A M.tb stimulation, however anti TB treatment reconstituted the response in TBDM and PTB patients. The household contacts revealed cytokine gene expression similar to that of patients and two of them developed the disease during follow-up.
CONCLUSION: Cytokine responses of the patients retained after treatment highlighting the antigen importance, hence further studies with recombinant cytokines may help in coming up with a biomarker. Analogous immune responses of household contacts with the TBDM and PTB patients may assist in recognizing the high risk individuals.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antigen85A; Cytokine production; Fold change; Household contacts; Tuberculosis with diabetes mellitus

Mesh:

Substances:

Year:  2016        PMID: 27002606     DOI: 10.1016/j.cyto.2016.03.009

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  6 in total

Review 1.  Cellular Immunity of Patients with Tuberculosis Combined with Diabetes.

Authors:  Peng Cheng; Liang Wang; Wenping Gong
Journal:  J Immunol Res       Date:  2022-06-01       Impact factor: 4.493

2.  16α-Bromoepiandrosterone as a new candidate for experimental diabetes-tuberculosis co-morbidity treatment.

Authors:  Manuel Othoniel López-Torres; Brenda Marquina-Castillo; Octavio Ramos-Espinosa; Dulce Mata-Espinosa; Jorge A Barrios-Payan; Guillermina Baay-Guzman; Sara Huerta Yepez; Estela Bini; Ivan Torre-Villalvazo; Nimbe Torres; Armando Tovar; William Chamberlin; Yu Ge; Andrea Carranza; Rogelio Hernández-Pando
Journal:  Clin Exp Immunol       Date:  2021-06-01       Impact factor: 5.732

3.  Effects of hMASP-2 on the formation of BCG infection-induced granuloma in the lungs of BALB/c mice.

Authors:  Xiaoying Xu; Xiaoling Lu; Xingfang Dong; Yanping Luo; Qian Wang; Xun Liu; Jie Fu; Yuan Zhang; Bingdong Zhu; Xingming Ma
Journal:  Sci Rep       Date:  2017-05-23       Impact factor: 4.379

4.  Genome-wide prediction and prioritization of human aging genes by data fusion: a machine learning approach.

Authors:  Masoud Arabfard; Mina Ohadi; Vahid Rezaei Tabar; Ahmad Delbari; Kaveh Kavousi
Journal:  BMC Genomics       Date:  2019-11-09       Impact factor: 3.969

5.  An Integrative Network Approach to Identify Common Genes for the Therapeutics in Tuberculosis and Its Overlapping Non-Communicable Diseases.

Authors:  Aftab Alam; Hala Abubaker Bagabir; Armiya Sultan; Mohd Faizan Siddiqui; Nikhat Imam; Mustfa F Alkhanani; Ahmad Alsulimani; Shafiul Haque; Romana Ishrat
Journal:  Front Pharmacol       Date:  2022-01-27       Impact factor: 5.810

Review 6.  Immunological Impacts of Diabetes on the Susceptibility of Mycobacterium tuberculosis.

Authors:  Birhanu Ayelign; Markos Negash; Meaza Genetu; Tadelo Wondmagegn; Tewodros Shibabaw
Journal:  J Immunol Res       Date:  2019-09-09       Impact factor: 4.818

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.